RBP7 and hepatocellular carcinoma: To determine whether the pathway is involved in RBP7 KD-induced cell proliferation inhibition, we used a specific p38 siRNA to reverse the p38 MAPK activation induced by RBP7 KD in HCC cells (Figure 6B).